|
1
|
Bushby KM: Diagnostic criteria for the
limb-girdle muscular dystrophies: Report of the ENMC consortium on
limb-girdle dystrophies. Neuromuscul Disord. 5:71–74.
1995.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Richard I, Hogrel JY, Stockholm D, Payan
CA, Fougerousse F, Calpainopathy Study Group, Eymard B, Mignard C,
Lopez de Munain A and Fardeau M: Urtizberea JALopez Fardeau
Urtizberea. Natural history of LGMD2A for delineating outcome
measures in clinical trials. Ann Clin Transl Neurol. 3:248–265.
2016.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Vissing J, Barresi R, Witting N, Van
Ghelue M, Gammelgaard L, Bindoff LA, Straub V, Lochmüller H, Hudson
J, Wahl CM, et al: A heterozygous 21-bp deletion in CAPN3 causes
dominantly inherited limb girdle muscular dystrophy. Brain.
139:2154–2163. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Straub V, Murphy A and Udd B: LGMD
workshop study group. 229th ENMC international workshop: Limb
girdle muscular dystrophies-nomenclature and reformed
classification Naarden, the Netherlands, 17-19 march 2017.
Neuromuscul Disord. 28:702–710. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang CH, Liang WC, Minami N, Nishino I and
Jong YJ: Limb-girdle muscular dystrophy type 2A with mutation in
CAPN3: The first report in Taiwan. Pediatr Neonatol. 56:62–65.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Martinez-Thompson JM, Moore SA and
Liewluck T: A novel CAPN3 mutation in late-onset limb-girdle
muscular dystrophy with early respiratory insufficiency. J Clin
Neurosci. 53:229–231. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mori-Yoshimura M, Segawa K, Minami N, Oya
Y, Komaki H, Nonaka I, Nishino I and Murata M: Cardiopulmonary
dysfunction in patients with limb-girdle muscular dystrophy 2A.
Muscle Nerve. 55:465–469. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Okere A, Reddy SS, Gupta S and Shinnar M:
A cardiomyopathy in a patient with limb girdle muscular dystrophy
type 2A. Circ Heart Fail. 6:e12–e13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yalvac ME, Amornvit J, Braganza C, Chen L,
Hussain SA, Shontz KM, Montgomery CL, Flanigan KM, Lewis S and
Sahenk Z: Impaired regeneration in calpain-3 null muscle is
associated with perturbations in mTORC1 signaling and defective
mitochondrial biogenesis. Skelet Muscle. 7(27)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sorimachi H, Hata S and Ono Y: Calpain
chronicle-an enzyme family under multidisciplinary
characterization. Proc Jpn Acad Ser B Phys Biol Sci. 87:287–327.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sorimachi H, Hata S and Ono Y: Impact of
genetic insights into calpain biology. J Biochem. 150:23–37.
2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rychlik W: OLIGO 7 primer analysis
software. Methods Mol Biol. 402:35–60. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Angelini C, Giaretta L and Marozzo R: An
update on diagnostic options and considerations in limb-girdle
dystrophies. Expert Rev Neurother. 18:693–703. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Anthony K, Cirak S, Torelli S, Tasca G,
Feng L, Arechavala-Gomeza V, Armaroli A, Guglieri M, Straathof CS,
Verschuuren JJ, et al: Dystrophin quantification and clinical
correlations in Becker muscular dystrophy: Implications for
clinical trials. Brain. 134:3547–3559. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Salem IH, Hsairi I, Mezghani N, Kenoun H,
Triki C and Fakhfakh F: CAPN3 mRNA processing alteration caused by
splicing mutation associated with novel genomic rearrangement of
Alu elements. J Hum Genet. 57:92–100. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hunt RC, Simhadri VL, Iandoli M, Sauna ZE
and Kimchi-Sarfaty C: Exposing synonymous mutations. Trends Genet.
30:308–321. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chamary JV, Parmley JL and Hurst LD:
Hearing silence: Non-neutral evolution at synonymous sites in
mammals. Nat Rev Genet. 7:98–108. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Blázquez L, Azpitarte M, Sáenz A,
Goicoechea M, Otaegui D, Ferrer X, Illa I, Gutierrez-Rivas E,
Vilchez JJ and López de Munain A: Characterization of novel CAPN3
isoforms in white blood cells: An alternative approach for
limb-girdle muscular dystrophy 2A diagnosis. Neurogenetics.
9:173–182. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bland A, Harrington EA, Dunn K, Pariani M,
Platt J, Grove ME and Caleshu C: Clinically impactful differences
in variant interpretation between clinicians and testing
laboratories: A single-center experience. Genet Med. 20:369–373.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fanin M, Nascimbeni AC, Fulizio L,
Trevisan CP, Meznaric-Petrusa M and Angelini C: Loss of calpain-3
autocatalytic activity in LGMD2A patients with normal protein
expression. Am J Pathol. 163:1929–1936. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Leidenroth A, Sorte HS, Gilfillan G,
Ehrlich M, Lyle R and Hewitt JE: Diagnosis by sequencing:
Correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome
analysis. Eur J Hum Genet. 20:999–1003. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Angelini C: Neuromuscular disease.
Diagnosis and discovery in limb-girdle muscular dystrophy. Nat Rev
Neurol. 12:6–8. 2016.PubMed/NCBI View Article : Google Scholar
|
